top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Autore Ecke Thorsten
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (240 p.)
Soggetto topico Medicine
Soggetto non controllato adjuvant chemotherapy
androgen receptor
BCG therapy
biomarker
biomarkers
BIRC5
bladder
bladder cancer
bladder cancer detection
cadmium exposure
cancer
chemotherapy
combination therapy
DNA methylation
drug resistance
ECRG4
ERBB2
F-actin
FGFR3
grade
heparan sulfate proteoglycans (HSPGs)
heparanase
histone demethylase
immunotherapy
invasion
ITIH5
JAK inhibitor
JAK-STAT pathway
KDM7A
KRT20
macrophage
metabolomics
Metallothionein
MIBC
miRNA
MS
muscle-invasive bladder cancer
n/a
NMR
non muscle invasive bladder cancer
non-invasive detection
oncolytic adenovirus
p53
personalized medicine
prediction
predictive biomarker
prognosis
proliferation
PTEN
quantitative PCR
RT-qPCR
somatic mutations
STAT3/5 inhibitor
survival
survivin
syndecan-1
TAGLN
TC-E 5002
telomerase
TERT promoter mutations
TERT promoter region
tumor marker
tumor markers
tumorigenesis
urinary biomarkers
urothelial cancer
urothelial carcinoma
urothelium
virotherapy
voided urine cytology
XVir-N-31
zinc transporter
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557142003321
Ecke Thorsten  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Outcomes and Therapeutic Management of Bladder Cancer
Outcomes and Therapeutic Management of Bladder Cancer
Autore Moschini Marco
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (120 p.)
Soggetto topico Medicine
Soggetto non controllato adjuvant
age
anesthesia recovery periods
biomarkers
bladder cancer
chemotherapy
clear-cell adenocarcinoma
cognitive impairment
female
FOXA1
gamma-cyclodextrins
GATA3
glycogen
human epidermal growth factor receptor 2
immunotherapy
indoleamine 2,3-dioxygenase
intracorporeal neobladder
KRT20
methylation
molecular markers
mRNA
muscle-invasive bladder cancer
n/a
neoadjuvant
neuromuscular blockade
nodal disease
open
outcome
outcomes
PCR
pN1
programmed death ligand-1
propensity score
radical cystectomy
robotic
robotic radical cystectomy
robotic-assisted
SEER program database
sex-sparing
survival
urinary bladder
urothelial carcinoma
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114503321
Moschini Marco  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui